QTTB Q32 Bio | 7/28/2026 | Boost Price Target | $15.21 | $36.00 | Buy | $0.00 00.00% ROI | |
CAPR Capricor Therapeutics | 7/27/2026 | Reiterated Rating | $7.00 | | Neutral | $0.00 00.00% ROI | |
LCTX Lineage Cell Therapeutics | 7/14/2026 | Reiterated Rating | $1.22 | | Buy | $0.00 00.00% ROI | |
NVCT Nuvectis Pharma | 6/22/2026 | Boost Price Target | $13.80 | $39.00 | Buy | $0.00 00.00% ROI | |
KRYS Krystal Biotech | 6/16/2026 | Boost Price Target | $322.09 | $361.00 | Buy | $0.00 00.00% ROI | |
CLDX Celldex Therapeutics | 6/15/2026 | Reiterated Rating | $31.27 | $42.00 | Buy | $0.00 00.00% ROI | |
NVCT Nuvectis Pharma | 6/12/2026 | Boost Price Target | $10.67 | $13.00 | Buy | $0.00 00.00% ROI | |
ANAB AnaptysBio | 6/10/2026 | Initiated Coverage | $51.63 | $95.00 | Buy | $0.00 00.00% ROI | |
BCDA BioCardia | 6/9/2026 | Reiterated Rating | $0.92 | $25.00 | Buy | $0.00 00.00% ROI | |
STTK Shattuck Labs | 6/8/2026 | Reiterated Rating | $4.93 | $18.00 | Buy | $0.00 00.00% ROI | |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
|
GUTS Fractyl Health | 6/4/2026 | Reiterated Rating | $0.78 | $8.00 | Buy | $0.00 00.00% ROI | |
TVTX Travere Therapeutics | 6/2/2026 | Boost Price Target | $43.12 | $67.00 | Buy | $0.00 00.00% ROI | |
RIGL Rigel Pharmaceuticals | 6/2/2026 | Reiterated Rating | $29.86 | $57.00 | Buy | $0.00 00.00% ROI | |
KRYS Krystal Biotech | 6/1/2026 | Reiterated Rating | $309.03 | $310.00 | Buy | $0.00 00.00% ROI | |
RIGL Rigel Pharmaceuticals | 5/22/2026 | Reiterated Rating | $29.19 | $57.00 | Buy | $0.00 00.00% ROI | |
KRYS Krystal Biotech | 5/18/2026 | Reiterated Rating | $306.29 | $310.00 | Buy | $0.00 00.00% ROI | |
PROK ProKidney | 5/18/2026 | Reiterated Rating | $1.63 | $12.00 | Buy | $0.00 00.00% ROI | |
LSTA Lisata Therapeutics | 5/15/2026 | Downgrade | $3.19 | | Neutral | $0.00 00.00% ROI | |
NEUP Neuphoria Therapeutics | 5/15/2026 | Downgrade | $4.74 | | Neutral | $0.00 00.00% ROI | |
CAPR Capricor Therapeutics | 5/13/2026 | Reiterated Rating | $31.52 | $60.00 | Buy | $0.00 00.00% ROI | |
CYTK Cytokinetics | 5/11/2026 | Boost Price Target | $76.91 | $140.00 | Buy | $0.00 00.00% ROI | |
TVTX Travere Therapeutics | 5/5/2026 | Boost Price Target | $44.91 | $57.00 | Buy | $0.00 00.00% ROI | |
QTTB Q32 Bio | 5/5/2026 | Reiterated Rating | $5.00 | $13.00 | Buy | $0.00 00.00% ROI | |
KRYS Krystal Biotech | 5/4/2026 | Reiterated Rating | $278.00 | $310.00 | Buy | $0.00 00.00% ROI | |
CLNN Clene | 5/4/2026 | Reiterated Rating | $6.71 | $31.00 | Buy | $0.00 00.00% ROI | |
ESPR Esperion Therapeutics | 5/1/2026 | Downgrade | $3.12 | $3.16 | Neutral | $0.00 00.00% ROI | |
XOMA XOMA Royalty | 4/30/2026 | Downgrade | $40.99 | $39.00 | Neutral | $0.00 00.00% ROI | |
LGND Ligand Pharmaceuticals | 4/30/2026 | Boost Price Target | $224.86 | $289.00 | Buy | $0.00 00.00% ROI | |
CMPX Compass Therapeutics | 4/27/2026 | Reiterated Rating | $1.92 | $24.00 | Buy | $0.00 00.00% ROI | |
GUTS Fractyl Health | 4/24/2026 | Reiterated Rating | $0.58 | $8.00 | Buy | $0.00 00.00% ROI | |
ANL Adlai Nortye | 4/20/2026 | Boost Price Target | $16.01 | $20.00 | Buy | $0.00 00.00% ROI | |
STTK Shattuck Labs | 4/20/2026 | Boost Price Target | $7.53 | $18.00 | Buy | $0.00 00.00% ROI | |
PDSB PDS Biotechnology | 4/15/2026 | Reiterated Rating | $1.29 | $15.00 | Buy | $0.00 00.00% ROI | |
TVTX Travere Therapeutics | 4/14/2026 | Reiterated Rating | $30.70 | $47.00 | Buy | $0.00 00.00% ROI | |
LGND Ligand Pharmaceuticals | 4/14/2026 | Boost Price Target | $230.97 | $243.00 | Buy | $0.00 00.00% ROI | |
CVKD Cadrenal Therapeutics | 4/7/2026 | Lower Price Target | $4.35 | $13.00 | Buy | $0.00 00.00% ROI | |
APRE Aprea Therapeutics | 3/31/2026 | Lower Price Target | $0.74 | $1.20 | Buy | $0.00 00.00% ROI | |
LCTX Lineage Cell Therapeutics | 3/24/2026 | Reiterated Rating | $1.44 | $9.00 | Buy | $0.00 00.00% ROI | |
PHAR Pharming Group | 3/24/2026 | Reiterated Rating | $16.08 | $37.00 | Buy | $0.00 00.00% ROI | |
VKTX Viking Therapeutics | 3/23/2026 | Reiterated Rating | $32.33 | $102.00 | Buy | $0.00 00.00% ROI | |
Buy this stock today (Ad) Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to move out of overpriced AI stocks before the tech trade breaks down and into lesser-known names with real potential to challenge the Mag 7.
One pick he calls 'an upgrade to Tesla stock' is a little-known company that just inked a partnership with Nvidia, positioning it ahead of Tesla in the autonomous vehicle race. Get the name, ticker, and full Hotlist before markets open |
LXRX Lexicon Pharmaceuticals | 3/23/2026 | Reiterated Rating | $1.63 | $6.00 | Buy | $0.00 00.00% ROI | |
XOMA XOMA Royalty | 3/20/2026 | Reiterated Rating | $28.76 | $97.00 | Buy | $0.00 00.00% ROI | |
LXRX Lexicon Pharmaceuticals | 3/12/2026 | Set Price Target | $1.70 | $6.00 | | $0.00 00.00% ROI | |
PHAR Pharming Group | 3/12/2026 | Set Price Target | $15.64 | $37.00 | Buy | $0.00 00.00% ROI | |
QTTB Q32 Bio | 3/10/2026 | Reiterated Rating | $6.01 | $13.00 | Buy | $0.00 00.00% ROI | |
ESPR Esperion Therapeutics | 3/10/2026 | Reiterated Rating | $2.73 | | Buy | $0.00 00.00% ROI | |
CAPR Capricor Therapeutics | 3/10/2026 | Reiterated Rating | $35.61 | $60.00 | Buy | $0.00 00.00% ROI | |
PHGE BiomX | 3/9/2026 | Downgrade | $7.10 | | Hold | $0.00 00.00% ROI | |
LCTX Lineage Cell Therapeutics | 3/6/2026 | Reiterated Rating | $1.91 | | Buy | $0.00 00.00% ROI | |
LXRX Lexicon Pharmaceuticals | 3/5/2026 | Boost Price Target | $1.68 | $6.00 | Buy | $0.00 00.00% ROI | |
QTTB Q32 Bio | 2/25/2026 | Initiated Coverage | $4.50 | $13.00 | Buy | $0.00 00.00% ROI | |
LGND Ligand Pharmaceuticals | 2/24/2026 | Boost Price Target | $189.97 | $239.00 | Buy | $0.00 00.00% ROI | |
FBIO Fortress Biotech | 2/23/2026 | Reiterated Rating | $3.66 | $17.00 | Buy | $0.00 00.00% ROI | |
ARMP Armata Pharmaceuticals | 2/23/2026 | Boost Price Target | $9.25 | $15.00 | Buy | $0.00 00.00% ROI | |
NAMS NewAmsterdam Pharma | 2/19/2026 | Upgrade | $34.63 | | Strong-Buy | $0.00 00.00% ROI | |
ANL Adlai Nortye | 2/13/2026 | Upgrade | $9.64 | $16.00 | Buy | $0.00 00.00% ROI | |
APRE Aprea Therapeutics | 1/29/2026 | Reiterated Rating | $0.58 | $4.00 | Buy | $0.00 00.00% ROI | |
CALC CalciMedica | 1/29/2026 | Reiterated Rating | $1.25 | | Neutral | $0.00 00.00% ROI | |
KURA Kura Oncology | 1/13/2026 | Reiterated Rating | $9.17 | $40.00 | Buy | $0.00 00.00% ROI | |
KRYS Krystal Biotech | 1/9/2026 | Reiterated Rating | $248.91 | $310.00 | Buy | $0.00 00.00% ROI | |
CYTK Cytokinetics | 12/22/2025 | Boost Price Target | $62.72 | $136.00 | Buy | $0.00 00.00% ROI | |
APRE Aprea Therapeutics | 12/18/2025 | Lower Price Target | $0.92 | $5.00 | Buy | $0.00 00.00% ROI | |
PROK ProKidney | 12/16/2025 | Initiated Coverage | $2.08 | $12.00 | Buy | $0.00 00.00% ROI | |
PROK ProKidney | 12/16/2025 | Initiated Coverage | $2.20 | $12.00 | Buy | $0.00 00.00% ROI | |
TNYA Tenaya Therapeutics | 12/12/2025 | Lower Price Target | $0.79 | $3.00 | Buy | $0.00 00.00% ROI | |
XOMA XOMA Royalty | 12/11/2025 | Lower Price Target | $26.13 | $97.00 | Buy | $0.00 00.00% ROI | |
NEUP Neuphoria Therapeutics | 12/5/2025 | Lower Price Target | $4.27 | $7.00 | Buy | $0.00 00.00% ROI | |
CAPR Capricor Therapeutics | 12/3/2025 | Boost Price Target | $27.67 | $60.00 | Buy | $0.00 00.00% ROI | |
NVCT Nuvectis Pharma | 12/3/2025 | Reiterated Rating | $5.81 | | Buy | $0.00 00.00% ROI | |
GUTS Fractyl Health | 12/2/2025 | Reiterated Rating | $1.48 | $8.00 | Buy | $0.00 00.00% ROI | |
STTK Shattuck Labs | 12/1/2025 | Upgrade | $2.06 | $6.00 | Buy | $0.00 00.00% ROI | |
TVTX Travere Therapeutics | 11/28/2025 | Reiterated Rating | $36.26 | $47.00 | Buy | $0.00 00.00% ROI | |
PHGE BiomX | 11/25/2025 | Boost Price Target | $0.29 | $26.00 | Buy | $0.00 00.00% ROI | |
LCTX Lineage Cell Therapeutics | 11/24/2025 | Reiterated Rating | $1.75 | $9.00 | Buy | $0.00 00.00% ROI | |
KURA Kura Oncology | 11/14/2025 | Reiterated Rating | $10.68 | $40.00 | Buy | $0.00 00.00% ROI | |
PDSB PDS Biotechnology | 11/13/2025 | Boost Price Target | $0.85 | $15.00 | Buy | $0.00 00.00% ROI | |
LGND Ligand Pharmaceuticals | 11/6/2025 | Boost Price Target | $208.50 | $231.00 | Buy | $0.00 00.00% ROI | |
FTH Sensei Biotherapeutics | 10/30/2025 | Downgrade | $10.06 | | Neutral | $0.00 00.00% ROI | |
IOVA Iovance Biotherapeutics | 10/29/2025 | Lower Price Target | $2.07 | $9.00 | Buy | $0.00 00.00% ROI | |
NAMS NewAmsterdam Pharma | 10/20/2025 | Initiated Coverage | $36.40 | $52.00 | Buy | $0.00 00.00% ROI | |
KURA Kura Oncology | 10/20/2025 | Reiterated Rating | $9.84 | $40.00 | Buy | $0.00 00.00% ROI | |
NAMS NewAmsterdam Pharma | 10/20/2025 | Initiated Coverage | $37.66 | $52.00 | Buy | $0.00 00.00% ROI | |
ATXS Astria Therapeutics | 10/16/2025 | Downgrade | $11.92 | | Hold | $0.00 00.00% ROI | |
RIGL Rigel Pharmaceuticals | 10/8/2025 | Reiterated Rating | $27.36 | $57.00 | Buy | $0.00 00.00% ROI | |
KURA Kura Oncology | 9/30/2025 | Reiterated Rating | $8.97 | $40.00 | Buy | $0.00 00.00% ROI | |
VKTX Viking Therapeutics | 9/29/2025 | Reiterated Rating | $25.65 | $102.00 | Buy | $0.00 00.00% ROI | |
CYTK Cytokinetics | 9/29/2025 | Reiterated Rating | $52.79 | $120.00 | Buy | $0.00 00.00% ROI | |
GUTS Fractyl Health | 9/26/2025 | Lower Price Target | $1.32 | $8.00 | Buy | $0.00 00.00% ROI | |
CAPR Capricor Therapeutics | 9/25/2025 | Reiterated Rating | $6.47 | $24.00 | Buy | $0.00 00.00% ROI | |
CYTK Cytokinetics | 9/22/2025 | Reiterated Rating | $48.66 | $120.00 | Buy | $0.00 00.00% ROI | |
Trump Takes Emergency Action - Plus Elon Musk's New Venture (Ad) Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Trump has issued emergency support to accelerate the rollout, and it's already live in multiple states.
The Financial Times reports Sam Altman is personally calling people to build this for OpenAI. A few little-known companies control the entire supply chain - meaning anyone who wants access must go through them. Their stocks are available to buy right now. See which companies control the supply chain behind this emerging tech |
BCDA BioCardia | 9/22/2025 | Reiterated Rating | $1.13 | $25.00 | Buy | $0.00 00.00% ROI | |
TVTX Travere Therapeutics | 9/19/2025 | Reiterated Rating | $24.19 | $47.00 | Buy | $0.00 00.00% ROI | |
ESPR Esperion Therapeutics | 9/19/2025 | Reiterated Rating | $2.75 | $16.00 | Buy | $0.00 00.00% ROI | |
ATXS Astria Therapeutics | 9/17/2025 | Boost Price Target | $7.76 | $20.00 | Buy | $0.00 00.00% ROI | |
GUTS Fractyl Health | 9/15/2025 | Initiated Coverage | $1.02 | $9.00 | Buy | $0.00 00.00% ROI | |
ATYR aTyr Pharma | 9/15/2025 | Downgrade | $1.12 | | Neutral | $0.00 00.00% ROI | |
KRYS Krystal Biotech | 9/15/2025 | Reiterated Rating | $153.21 | $240.00 | Buy | $0.00 00.00% ROI | |
CAPR Capricor Therapeutics | 9/11/2025 | Reiterated Rating | $6.30 | $24.00 | Buy | $0.00 00.00% ROI | |
TVTX Travere Therapeutics | 9/10/2025 | Reiterated Rating | $27.53 | $47.00 | Buy | $0.00 00.00% ROI | |
TVTX Travere Therapeutics | 9/3/2025 | Reiterated Rating | $19.40 | $47.00 | Buy | $0.00 00.00% ROI | |
TNYA Tenaya Therapeutics | 9/2/2025 | Reiterated Rating | $1.13 | $5.00 | Buy | $0.00 00.00% ROI | |
LXRX Lexicon Pharmaceuticals | 9/2/2025 | Reiterated Rating | $1.11 | $4.00 | Buy | $0.00 00.00% ROI | |
TVTX Travere Therapeutics | 8/28/2025 | Boost Price Target | $17.44 | $47.00 | Buy | $0.00 00.00% ROI | |
LGND Ligand Pharmaceuticals | 8/28/2025 | Boost Price Target | $160.51 | $206.00 | Buy | $0.00 00.00% ROI | |
TNYA Tenaya Therapeutics | 8/27/2025 | Reiterated Rating | $1.08 | $5.00 | Buy | $0.00 00.00% ROI | |
NEUP Neuphoria Therapeutics | 8/26/2025 | Reiterated Rating | $7.40 | $21.00 | Buy | $0.00 00.00% ROI | |
KRYS Krystal Biotech | 8/22/2025 | Reiterated Rating | $145.70 | $240.00 | Buy | $0.00 00.00% ROI | |
LSTA Lisata Therapeutics | 8/21/2025 | Reiterated Rating | $2.40 | $15.00 | Buy | $0.00 00.00% ROI | |
FBIO Fortress Biotech | 8/21/2025 | Lower Price Target | $2.05 | $17.00 | Buy | $0.00 00.00% ROI | |
CLDX Celldex Therapeutics | 8/20/2025 | Lower Price Target | $24.02 | $42.00 | Buy | $0.00 00.00% ROI | |
PHGE BiomX | 8/20/2025 | Reiterated Rating | $10.41 | $285.00 | Buy | $0.00 00.00% ROI | |
IOVA Iovance Biotherapeutics | 8/19/2025 | Reiterated Rating | $2.50 | $20.00 | Buy | $0.00 00.00% ROI | |
VKTX Viking Therapeutics | 8/19/2025 | Reiterated Rating | $23.90 | $102.00 | Buy | $0.00 00.00% ROI | |
ATXS Astria Therapeutics | 8/13/2025 | Reiterated Rating | $6.65 | $16.00 | Buy | $0.00 00.00% ROI | |
FTH Sensei Biotherapeutics | 8/5/2025 | Reiterated Rating | $8.20 | $30.00 | Buy | $0.00 00.00% ROI | |
NVCT Nuvectis Pharma | 8/4/2025 | Lower Price Target | $7.01 | $10.00 | Buy | $0.00 00.00% ROI | |
VYNE VYNE Therapeutics | 7/30/2025 | Downgrade | $0.39 | | Neutral | $0.00 00.00% ROI | |
KRYS Krystal Biotech | 7/25/2025 | Reiterated Rating | $150.00 | $240.00 | Buy | $000.00 00.00% ROI | |
CAPR Capricor Therapeutics | 7/11/2025 | Lower Price Target | $7.94 | $24.00 | Buy | $00.00 00.00% ROI | |
PDSB PDS Biotechnology | 7/1/2025 | Reiterated Rating | $1.33 | $13.00 | Buy | $0.00 00.00% ROI | |
EWTX Edgewise Therapeutics | 6/30/2025 | Initiated Coverage | $13.17 | $42.00 | Buy | $00.00 00.00% ROI | |
VKTX Viking Therapeutics | 6/25/2025 | Reiterated Rating | $26.08 | $102.00 | Buy | $00.00 00.00% ROI | |
LXRX Lexicon Pharmaceuticals | 6/24/2025 | Reiterated Rating | $0.73 | $4.00 | Buy | $0.00 00.00% ROI | |
ATNM Actinium Pharmaceuticals | 6/24/2025 | Reiterated Rating | $1.52 | $4.00 | Buy | $0.00 00.00% ROI | |
CAPR Capricor Therapeutics | 6/24/2025 | Reiterated Rating | $8.47 | $77.00 | Buy | $00.00 00.00% ROI | |
KRYS Krystal Biotech | 6/24/2025 | Reiterated Rating | $143.72 | $240.00 | Buy | $000.00 00.00% ROI | |
LCTX Lineage Cell Therapeutics | 6/23/2025 | Reiterated Rating | $0.95 | $9.00 | Buy | $0.00 00.00% ROI | |
CDTX Cidara Therapeutics | 6/18/2025 | Upgrade | $22.10 | $41.00 | Buy | $0.00 00.00% ROI | |
ESPR Esperion Therapeutics | 6/17/2025 | Reiterated Rating | $1.17 | $16.00 | Buy | $0.00 00.00% ROI | |
BLRX BioLineRx | 6/17/2025 | Reiterated Rating | $4.67 | | Buy | $0.00 00.00% ROI | |
CLDX Celldex Therapeutics | 6/13/2025 | Reiterated Rating | $20.35 | $50.00 | Buy | $00.00 00.00% ROI | |
CAPR Capricor Therapeutics | 6/13/2025 | Reiterated Rating | $12.51 | $77.00 | Buy | $00.00 00.00% ROI | |
ATXS Astria Therapeutics | 6/13/2025 | Reiterated Rating | $5.89 | $16.00 | Buy | $0.00 00.00% ROI | |
PDSB PDS Biotechnology | 6/11/2025 | Reiterated Rating | $1.68 | $13.00 | Buy | $0.00 00.00% ROI | |
MBRX Moleculin Biotech | 6/9/2025 | Upgrade | $16.75 | $100.00 | Buy | $0.00 00.00% ROI | |
PHIO Phio Pharmaceuticals | 6/5/2025 | Initiated Coverage | $2.10 | $14.00 | Buy | $0.00 00.00% ROI | |
ATYR aTyr Pharma | 6/4/2025 | Reiterated Rating | $5.32 | $35.00 | Buy | $0.00 00.00% ROI | |
ANL Adlai Nortye | 6/2/2025 | Downgrade | $1.57 | | Neutral | $00.00 00.00% ROI | |
BLRX BioLineRx | 5/28/2025 | Reiterated Rating | $3.68 | | Buy | $0.00 00.00% ROI | |
XOMA XOMA Royalty | 5/28/2025 | Reiterated Rating | $24.92 | $104.00 | Buy | $00.00 00.00% ROI | |
The end may be near for these iconic stocks (Ad) Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are triggering a historic wealth transfer already underway in 2026. Household names like Intuit (-57%), Boston Scientific (-49%), and Tractor Supply (-40%) are cratering, while lesser-known companies like Sandisk (+573%) and Rackspace (+444%) surge.
Chaikin has identified specific stocks he believes investors should sell before they fall further - and the names may surprise you. He's also pinpointing a company tapped as Nvidia's self-driving partner and a potential AI megadeal that could split into three high-growth stocks.
Stream his free presentation to get every buy and sell recommendation with no membership or credit card required. Watch Marc Chaikin's free presentation and get his full buy-and-sell list today |
CRIS Curis | 5/19/2025 | Reiterated Rating | $40.60 | $340.00 | Buy | $0.00 00.00% ROI | |
ATYR aTyr Pharma | 5/19/2025 | Reiterated Rating | $3.27 | $35.00 | Buy | $0.00 00.00% ROI | |
ARMP Armata Pharmaceuticals | 5/19/2025 | Boost Price Target | $1.74 | $9.00 | Buy | $0.00 00.00% ROI | |
PHGE BiomX | 5/16/2025 | Lower Price Target | $10.71 | $285.00 | Buy | $0.00 00.00% ROI | |
CVKD Cadrenal Therapeutics | 5/16/2025 | Reiterated Rating | $15.14 | $32.00 | Buy | $0.00 00.00% ROI | |
CALC CalciMedica | 5/15/2025 | Reiterated Rating | $1.91 | $16.00 | Buy | $0.00 00.00% ROI | |
ATNM Actinium Pharmaceuticals | 5/12/2025 | Reiterated Rating | $1.55 | $4.00 | Buy | $0.00 00.00% ROI | |
IOVA Iovance Biotherapeutics | 5/9/2025 | Lower Price Target | $3.17 | $20.00 | Buy | $0.00 00.00% ROI | |
ITRM Iterum Therapeutics | 5/8/2025 | Reiterated Rating | $0.92 | $9.00 | Buy | $0.00 00.00% ROI | |
BMEA Biomea Fusion | 5/6/2025 | Lower Price Target | $2.00 | $18.00 | Buy | $0.00 00.00% ROI | |
CLDX Celldex Therapeutics | 5/6/2025 | Reiterated Rating | $20.29 | $80.00 | Buy | $00.00 00.00% ROI | |
KRYS Krystal Biotech | 5/6/2025 | Reiterated Rating | $141.18 | $240.00 | Buy | $000.00 00.00% ROI | |
NVCT Nuvectis Pharma | 4/30/2025 | Reiterated Rating | $10.33 | $15.00 | Buy | $0.00 00.00% ROI | |
KRYS Krystal Biotech | 4/28/2025 | Boost Price Target | $167.35 | $240.00 | Buy | $000.00 00.00% ROI | |
KURA Kura Oncology | 4/28/2025 | Reiterated Rating | $6.41 | $40.00 | Buy | $0.00 00.00% ROI | |
ATNM Actinium Pharmaceuticals | 4/28/2025 | Reiterated Rating | $1.34 | $4.00 | Buy | $0.00 00.00% ROI | |
TNYA Tenaya Therapeutics | 4/25/2025 | Reiterated Rating | $0.46 | $5.00 | Buy | $0.00 00.00% ROI | |
ESPR Esperion Therapeutics | 4/25/2025 | Reiterated Rating | $0.88 | $16.00 | Buy | $0.00 00.00% ROI | |
VYNE VYNE Therapeutics | 4/25/2025 | Lower Price Target | $69.50 | $225.00 | Buy | $00.00 00.00% ROI | |
VKTX Viking Therapeutics | 4/24/2025 | Reiterated Rating | $25.84 | $102.00 | Buy | $00.00 00.00% ROI | |
CMPX Compass Therapeutics | 4/21/2025 | Reiterated Rating | $1.78 | $24.00 | Buy | $0.00 00.00% ROI | |
CYTK Cytokinetics | 4/21/2025 | Reiterated Rating | $38.01 | $120.00 | Buy | $00.00 00.00% ROI | |
VKTX Viking Therapeutics | 4/17/2025 | Reiterated Rating | $23.45 | $102.00 | Buy | $00.00 00.00% ROI | |
CYTK Cytokinetics | 4/15/2025 | Reiterated Rating | $39.07 | $120.00 | Buy | $00.00 00.00% ROI | |
TPST Tempest Therapeutics | 4/10/2025 | Reiterated Rating | $7.15 | $16.00 | Neutral | $0.00 00.00% ROI | |
XBIO Xenetic Biosciences | 4/9/2025 | Reiterated Rating | $2.38 | | Neutral | $0.00 00.00% ROI | |
CLNN Clene | 4/8/2025 | Reiterated Rating | $2.99 | $31.00 | Buy | $0.00 00.00% ROI | |
PHGE BiomX | 4/4/2025 | Reiterated Rating | $11.13 | $399.00 | Buy | $0.00 00.00% ROI | |
CMPX Compass Therapeutics | 4/4/2025 | Boost Price Target | $1.61 | $24.00 | Buy | $0.00 00.00% ROI | |
CYTK Cytokinetics | 4/4/2025 | Reiterated Rating | $40.52 | $120.00 | Buy | $00.00 00.00% ROI | |
KAPA Kairos Pharma | 4/3/2025 | Initiated Coverage | $0.92 | $12.00 | Buy | $0.00 00.00% ROI | |
PHGE BiomX | 4/1/2025 | Boost Price Target | $10.56 | $399.00 | Buy | $0.00 00.00% ROI | |
CALC CalciMedica | 4/1/2025 | Reiterated Rating | $1.91 | $16.00 | Buy | $0.00 00.00% ROI | |
ATNM Actinium Pharmaceuticals | 4/1/2025 | Reiterated Rating | $1.61 | $4.00 | Buy | $0.00 00.00% ROI | |
BMEA Biomea Fusion | 3/31/2025 | Reiterated Rating | $2.30 | $40.00 | Buy | $0.00 00.00% ROI | |
TNYA Tenaya Therapeutics | 3/31/2025 | Reiterated Rating | $0.61 | $5.00 | Buy | $0.00 00.00% ROI | |
BLRX BioLineRx | 3/31/2025 | Boost Price Target | $3.03 | $26.00 | Buy | $0.00 00.00% ROI | |
APTO Aptose Biosciences | 3/28/2025 | Boost Price Target | $3.33 | $6.00 | Buy | $0.00 00.00% ROI | |
XOMA XOMA Royalty | 3/28/2025 | Reiterated Rating | $20.97 | $104.00 | Buy | $00.00 00.00% ROI | |
TPST Tempest Therapeutics | 3/28/2025 | Lower Price Target | $10.92 | $208.00 | Buy | $0.00 00.00% ROI | |
LXRX Lexicon Pharmaceuticals | 3/28/2025 | Reiterated Rating | $0.63 | $4.00 | Buy | $0.00 00.00% ROI | |
PDSB PDS Biotechnology | 3/27/2025 | Lower Price Target | $1.25 | $13.00 | Buy | $0.00 00.00% ROI | |
VKTX Viking Therapeutics | 3/26/2025 | Reiterated Rating | $26.07 | $102.00 | Buy | $00.00 00.00% ROI | |
ATNM Actinium Pharmaceuticals | 3/25/2025 | Reiterated Rating | $1.73 | $4.00 | Buy | $0.00 00.00% ROI | |
BMEA Biomea Fusion | 3/24/2025 | Reiterated Rating | $2.87 | $40.00 | Buy | $0.00 00.00% ROI | |
CLNN Clene | 3/24/2025 | Reiterated Rating | $4.06 | $31.00 | Buy | $0.00 00.00% ROI | |
XBIO Xenetic Biosciences | 3/20/2025 | Reiterated Rating | $3.64 | | Neutral | $0.00 00.00% ROI | |
PHAR Pharming Group | 3/20/2025 | Reiterated Rating | $8.86 | $37.00 | Buy | $00.00 00.00% ROI | |
ESPR Esperion Therapeutics | 3/20/2025 | Reiterated Rating | $1.62 | $16.00 | Buy | $0.00 00.00% ROI | |
XOMA XOMA Royalty | 3/19/2025 | Reiterated Rating | $20.89 | $104.00 | Buy | $00.00 00.00% ROI | |
A letter from Shannon Stansberry (Ad) Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief.
It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live. Watch the full story and see the verified track record for yourself |
OABI OmniAb | 3/19/2025 | Reiterated Rating | $3.19 | $11.00 | Buy | $0.00 00.00% ROI | |
ATNM Actinium Pharmaceuticals | 3/18/2025 | Reiterated Rating | $1.24 | $4.00 | Buy | $0.00 00.00% ROI | |
CAPR Capricor Therapeutics | 3/17/2025 | Reiterated Rating | $13.23 | $77.00 | Buy | $00.00 00.00% ROI | |
ATYR aTyr Pharma | 3/14/2025 | Reiterated Rating | $3.99 | $35.00 | Buy | $0.00 00.00% ROI | |
PHAR Pharming Group | 3/14/2025 | Reiterated Rating | $8.74 | $37.00 | Buy | $00.00 00.00% ROI | |
PDSB PDS Biotechnology | 3/13/2025 | Reiterated Rating | $1.27 | $21.00 | Buy | $0.00 00.00% ROI | |
CLNN Clene | 3/12/2025 | Reiterated Rating | $4.41 | $31.00 | Buy | $0.00 00.00% ROI | |
LCTX Lineage Cell Therapeutics | 3/11/2025 | Reiterated Rating | $0.53 | $9.00 | Buy | $0.00 00.00% ROI | |
TNYA Tenaya Therapeutics | 3/11/2025 | Lower Price Target | $0.51 | $5.00 | Buy | $0.00 00.00% ROI | |
ATNM Actinium Pharmaceuticals | 3/11/2025 | Reiterated Rating | $1.12 | $4.00 | Buy | $0.00 00.00% ROI | |
VKTX Viking Therapeutics | 3/11/2025 | Reiterated Rating | $25.36 | $102.00 | Buy | $00.00 00.00% ROI | |
ATXS Astria Therapeutics | 3/11/2025 | Reiterated Rating | $5.91 | $16.00 | Buy | $0.00 00.00% ROI | |
PDSB PDS Biotechnology | 3/7/2025 | Reiterated Rating | $1.28 | $21.00 | Buy | $0.00 00.00% ROI | |
VYNE VYNE Therapeutics | 3/6/2025 | Reiterated Rating | $115.50 | $287.50 | Buy | $00.00 00.00% ROI | |
RIGL Rigel Pharmaceuticals | 3/5/2025 | Reiterated Rating | $22.08 | $57.00 | Buy | $00.00 00.00% ROI | |
CALC CalciMedica | 3/4/2025 | Reiterated Rating | $2.20 | $16.00 | Buy | $0.00 00.00% ROI | |
ESPR Esperion Therapeutics | 3/4/2025 | Reiterated Rating | $1.76 | $16.00 | Buy | $0.00 00.00% ROI | |
CAPR Capricor Therapeutics | 3/4/2025 | Reiterated Rating | $14.23 | $77.00 | Buy | $00.00 00.00% ROI | |
LXRX Lexicon Pharmaceuticals | 3/3/2025 | Reiterated Rating | $0.35 | $4.00 | Buy | $0.00 00.00% ROI | |
IOVA Iovance Biotherapeutics | 2/28/2025 | Reiterated Rating | $5.26 | $32.00 | Buy | $0.00 00.00% ROI | |
CLDX Celldex Therapeutics | 2/28/2025 | Reiterated Rating | $20.31 | $80.00 | Buy | $00.00 00.00% ROI | |
CYTK Cytokinetics | 2/28/2025 | Reiterated Rating | $47.45 | $120.00 | Buy | $00.00 00.00% ROI | |
KRYS Krystal Biotech | 2/28/2025 | Reiterated Rating | $176.56 | $221.00 | Buy | $000.00 00.00% ROI | |
KURA Kura Oncology | 2/27/2025 | Reiterated Rating | $7.77 | $40.00 | Buy | $0.00 00.00% ROI | |
ATXS Astria Therapeutics | 2/27/2025 | Reiterated Rating | $6.45 | $16.00 | Buy | $0.00 00.00% ROI | |
CLNN Clene | 2/25/2025 | Reiterated Rating | $4.33 | $31.00 | Buy | $0.00 00.00% ROI | |
NVCT Nuvectis Pharma | 2/25/2025 | Lower Price Target | $7.06 | $11.00 | Buy | $0.00 00.00% ROI | |
PDSB PDS Biotechnology | 2/24/2025 | Reiterated Rating | $1.23 | $21.00 | Buy | $0.00 00.00% ROI | |
VYNE VYNE Therapeutics | 2/19/2025 | Reiterated Rating | $131.90 | $287.50 | Buy | $00.00 00.00% ROI | |
KRYS Krystal Biotech | 2/19/2025 | Reiterated Rating | $171.70 | $221.00 | Buy | $000.00 00.00% ROI | |
PTNT Palatin Technologies | 2/13/2025 | Lower Price Target | $54.25 | $350.00 | Buy | $0.00 00.00% ROI | |
APTO Aptose Biosciences | 2/12/2025 | Reiterated Rating | $6.70 | $60.00 | Buy | $0.00 00.00% ROI | |
ESPR Esperion Therapeutics | 2/11/2025 | Reiterated Rating | $1.86 | $16.00 | Buy | $0.00 00.00% ROI | |
LCTX Lineage Cell Therapeutics | 2/11/2025 | Reiterated Rating | $0.64 | $9.00 | Buy | $0.00 00.00% ROI | |
PTNT Palatin Technologies | 2/7/2025 | Reiterated Rating | $49.50 | $850.00 | Buy | $0.00 00.00% ROI | |
KURA Kura Oncology | 2/6/2025 | Boost Price Target | $9.05 | $40.00 | Buy | $0.00 00.00% ROI | |
VKTX Viking Therapeutics | 2/6/2025 | Reiterated Rating | $33.50 | $102.00 | Buy | $00.00 00.00% ROI | |
NEUP Neuphoria Therapeutics | 2/4/2025 | Boost Price Target | $5.10 | $21.00 | Buy | $0.00 00.00% ROI | |
XOMA XOMA Royalty | 2/3/2025 | Lower Price Target | $26.61 | $104.00 | Buy | $00.00 00.00% ROI | |
LCTX Lineage Cell Therapeutics | 1/31/2025 | Reiterated Rating | $0.63 | $9.00 | Buy | $0.00 00.00% ROI | |
LXRX Lexicon Pharmaceuticals | 1/29/2025 | Reiterated Rating | $0.93 | $4.00 | Buy | $0.00 00.00% ROI | |
PTNT Palatin Technologies | 1/28/2025 | Reiterated Rating | $46.50 | $850.00 | Buy | $0.00 00.00% ROI | |
ESPR Esperion Therapeutics | 1/23/2025 | Reiterated Rating | $2.20 | $16.00 | Buy | $0.00 00.00% ROI | |
ATXS Astria Therapeutics | 1/23/2025 | Reiterated Rating | $7.53 | $16.00 | Buy | $00.00 00.00% ROI | |
RIGL Rigel Pharmaceuticals | 1/22/2025 | Reiterated Rating | $21.29 | $57.00 | Buy | $00.00 00.00% ROI | |
CYTK Cytokinetics | 1/21/2025 | Reiterated Rating | $45.72 | $120.00 | Buy | $00.00 00.00% ROI | |
VKTX Viking Therapeutics | 1/17/2025 | Reiterated Rating | $33.66 | $102.00 | Buy | $00.00 00.00% ROI | |
APRE Aprea Therapeutics | 1/15/2025 | Reiterated Rating | $3.77 | $20.00 | Buy | $0.00 00.00% ROI | |
TNYA Tenaya Therapeutics | 1/14/2025 | Reiterated Rating | $1.50 | $18.00 | Buy | $0.00 00.00% ROI | |
RIGL Rigel Pharmaceuticals | 1/14/2025 | Reiterated Rating | $17.11 | $57.00 | Buy | $00.00 00.00% ROI | |
VYNE VYNE Therapeutics | 1/14/2025 | Reiterated Rating | $151.00 | $287.50 | Buy | $00.00 00.00% ROI | |
BMEA Biomea Fusion | 1/14/2025 | Reiterated Rating | $4.15 | $40.00 | Buy | $0.00 00.00% ROI | |
ATXS Astria Therapeutics | 1/13/2025 | Reiterated Rating | $7.27 | $16.00 | Buy | $00.00 00.00% ROI | |
APTO Aptose Biosciences | 1/10/2025 | Reiterated Rating | $6.40 | $60.00 | Buy | $0.00 00.00% ROI | |
ESPR Esperion Therapeutics | 1/10/2025 | Reiterated Rating | $2.17 | | Buy | $0.00 00.00% ROI | |
CYTK Cytokinetics | 1/10/2025 | Reiterated Rating | $47.37 | $120.00 | Buy | $00.00 00.00% ROI | |
VKTX Viking Therapeutics | 1/8/2025 | Reiterated Rating | $41.52 | $102.00 | Buy | $00.00 00.00% ROI | |
CMPX Compass Therapeutics | 1/8/2025 | Reiterated Rating | $1.77 | $10.00 | Buy | $0.00 00.00% ROI | |
PHGE BiomX | 1/8/2025 | Reiterated Rating | $14.05 | $38.00 | Buy | $0.00 00.00% ROI | |
CYTK Cytokinetics | 10/17/2024 | Reiterated Rating | $55.28 | $120.00 | Buy | $00.00 00.00% ROI | |